Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 342RC | — |
AE Priorix - Administration of only the diluent.; AE Priorix - Administration of only the diluent.; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 64-year-old female patient who received MMR (Priorix) (batch number 342RC, expiry date 01-MAY-2025) for prophylaxis. On 28-FEB-2025, the patient received Priorix. On 28-FEB-2025, an unknown time after receiving Priorix, the patient experienced inappropriate dose of vaccine administered (Verbatim: AE Priorix - Administration of only the diluent.) and inappropriate preparation of medication (Verbatim: AE Priorix - Administration of only the diluent.). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-MAR-2025 The nurse reported that the two patients that likely received an incomplete Priorix dose, but they could not confirm which patient received only the diluent portion, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered The nurse thought they should revaccinate both patients but one of them would receive an extra dose. The nurse asked for information about a patient receiving an extra dose of Priorix or if they could check titers prior to revaccination and asked what was the recommendation in that situation. This case is linked with US2025038563, reported by same reporter.; Sender's Comments: US-GSK-US2025038563:Same reporter/Different Patient